Osteoporosis involves chronic inflammatory responses where certain proinflammatory markers (e.g., tumor necrosis factor alpha, interleukin-1b, and interleukin-6) enhance osteoclast activity, reducing bone density [44,45,46]. Here, IL6 is linked to osteoporosis.